Sparasci Davide, Fanfulla Francesco, Ferri Raffaele, Aricò Debora, Distefano Daniela, Pravatà Emanuele, Heinzer Raphael, Haba-Rubio José, Berger Mathieu, Riccitelli Gianna Carla, Gobbi Claudio, Zecca Chiara, Manconi Mauro
Sleep Medicine Unit, Neurocenter of Southern Switzerland, Lugano, Switzerland.
Sleep Medicine Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Scientific Institute of Pavia, Pavia, Italy.
Nat Sci Sleep. 2022 Apr 20;14:741-750. doi: 10.2147/NSS.S359858. eCollection 2022.
Multiple sclerosis (MS) represents a risk factor for sleep disorders, but there are conflicting results about the prevalence and severity of sleep-related breathing disorders (SRBD) in MS. Most available data come from self-administered questionnaires.
To conduct a polysomnographic study in MS focused on SRBD, compared to a group of healthy controls (HC), also considering the neuroimaging findings. To evaluate the impact of SRBD on vigilance, fatigue and depression in MS.
In this cross-sectional, observational, instrumental study, 67 MS patients (men/women: 20/47; mean age: 50.6±8.2 years) underwent PSG and maintenance of wakefulness test. Findings were compared to 67 age-, sex-, BMI-matched HC, by using parametric (Student's -test) and nonparametric statistics (chi-squared test). A subgroup analysis was then performed, evaluating the influence of brainstem (mesencephalic, pontine and medullary) lesions at neuroimaging on instrumental and clinical data: MS patients with at least one brainstem lesion vs MS patients without vs HC.
The frequency of SRBD was comparable in MS patients and HC. No MS patient had a central apnea index ≥2/h. The respiratory disturbance index (RDI) did not correlate to clinical parameters such as fatigue and depression. Patients with MS were drowsier than HC (47% vs 26%, p = 0.019) and showed a worse sleep pattern, in terms of duration, efficiency and architecture.
Our study does not provide evidence of an association between MS-specific symptoms such as fatigue, sleepiness, depression and central or obstructive apneas, even in the presence of brainstem lesions.
多发性硬化症(MS)是睡眠障碍的一个风险因素,但关于MS患者睡眠相关呼吸障碍(SRBD)的患病率和严重程度,研究结果存在冲突。大多数现有数据来自自我管理问卷。
对MS患者进行一项多导睡眠图研究,重点关注SRBD,并与一组健康对照者(HC)进行比较,同时考虑神经影像学检查结果。评估SRBD对MS患者警觉性、疲劳和抑郁的影响。
在这项横断面、观察性、仪器研究中,67例MS患者(男/女:20/47;平均年龄:50.6±8.2岁)接受了多导睡眠图检查和清醒维持测试。通过参数统计(学生t检验)和非参数统计(卡方检验),将结果与67例年龄、性别、体重指数匹配的HC进行比较。然后进行亚组分析,评估神经影像学检查发现的脑干(中脑、脑桥和延髓)病变对仪器检查和临床数据的影响:至少有一处脑干病变的MS患者与无脑干病变的MS患者及HC。
MS患者和HC中SRBD的发生率相当。没有MS患者的中枢性呼吸暂停指数≥2次/小时。呼吸紊乱指数(RDI)与疲劳和抑郁等临床参数无关。MS患者比HC更容易困倦(47%对26%,p = 0.019),并且在睡眠时间、睡眠效率和睡眠结构方面表现出更差的睡眠模式。
即使存在脑干病变,我们的研究也没有提供证据表明MS特异性症状如疲劳、嗜睡、抑郁与中枢性或阻塞性呼吸暂停之间存在关联。